Furthermore, TLR-4 can affect tumor resistance by modulating key processes within the tumor microenvironment, including epithelial-mesenchymal transition (EMT), stemness maintenance, and stromal immunosuppression [63]. The gene discussed is TLR4; the disease is neoplasm.